FDA warnings associated with reduced atypical antipsychotic use among older adults with dementia
Tuesday, January 12, 2010 - 07:35
in Health & Medicine
The use of atypical antipsychotics to treat elderly patients with dementia appears to have decreased following a 2005 Food and Drug Administration (FDA) advisory regarding the risks of these medications in this population, according to a report in the January 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals...